Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E. E. Gushchina
Observed names:
E.E. Gushchina,
Elizaveta E. Gushchina,
Е.Е. Гущина
Institutions:
Ministry of Health of the Russian Federation,
P.A. Hertzen Moscow Oncology Research Institute
Observed institutions:
Ministry of Health of the Russian Federation,
P.A. Hertzen Moscow Oncology Research Institute,
Federal Medical-Biological Agency
ORCID:
0000-0002-5625-3635
Observed ORCID:
0000-0002-5625-3635
OpenAlex ID:
A5068568936
Chronic obstructive pulmonary disease related to workplace aerosol exposure
2013
·
O. S. Vasilieva
, A. A. Gusakov
, et al.
·
PULMONOLOGIYA
·
5
Treatment of primary central nervous system lymphomas
2021
·
I. V. Cherkashina
, M. A. Vernyuk
, et al.
·
Oncohematology
·
2
PDF
Early progression of follicular lymphoma: a view of the problem and personal experience
2022
·
M. A. Vernyuk
, A. M. Chervontseva
, et al.
·
Oncohematology
·
1
PDF
Modern aspects of the diagnosis and treatment of primary central nervous system lymphomas
2022
·
I.V. Cherkashina
, M.A. Vernyuk
, et al.
·
P A Herzen Journal of Oncology
·
1
Results of Treatment of Primary Patients with Diffuse B-Large-Cell Lymphoma Depending on IPI and Performing High-Dose Consolidation Followed by Transplantation of Autologous Hematopoietic Stem Cells
2021
·
Н.И. Стуклов
, М.А. Вернюк
, et al.
·
Гематология Трансфузиология Восточная Европа
·
1
PDF
Experience in the Treatment of Refractory Hodgkin’s Lymphoma
2021
·
A. M. Chervontseva
, M. A. Verniuk
, et al.
·
Siberian Journal of Oncology
·
1
PDF
Immunochemotherapy of refractory classical Hodgkin's lymphoma with high-dose consolidation and autologous hematopoietic stem cell transplantation complicated by a new coronavirus infection
2022
·
L. S. Khayrullina
, M. A. Vernyuk
, et al.
·
Oncohematology
PDF
Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report
2022
·
Elizaveta E. Gushchina
, Maria A. Vernyuk
, et al.
·
Journal of Modern Oncology
PDF
Comparative evaluation of the effectiveness of primary treatment regimens in patients with classical Hodgkin’s lymphoma from the group of unfavorable prognosis
2021
·
A. M. Chervontseva
, M. A. Verniuk
, et al.
·
Oncohematology
PDF
Show more works
View as search
Works count:
9
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type